Other
Drug Repurposing
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Drug Repurposing is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Completed14 · 88%
Recruiting1 · 6%
Unknown status1 · 6%
Clinical Trials
Trial Activity
16 trials
Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells
Recruiting·—·N/A·NCT06967831·80 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tofacitinib vs Abatacept
Completed·—·N/A·NCT04529876·29,464 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - TNFi vs Abatacept
Completed·—·N/A·NCT04529902·63,013 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol
Completed·—·N/A·NCT04746989·294,878 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol
Completed·—·N/A·NCT05794997·817,337 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Amiloride vs Triamterene
Completed·—·N/A·NCT05125237·155,963 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tocilizumab vs Abatacept
Completed·—·N/A·NCT04529863·30,432 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic Antagonists
Completed·—·N/A·NCT05457868·124,117 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Dihydropyridine Calcium Channel Blockers Versus Hydrochlorothiazide
Completed·—·N/A·NCT05125224·163,720 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Completed·—·N/A·NCT05457855·51,533 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs Hydroxychloroquine
Completed·—·N/A·NCT04691505·133,553 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Pentoxifylline Versus Cilostazol
Completed·—·N/A·NCT05635370·10,398 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole
Completed·—·N/A·NCT05635357·16,989 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - PDE5
Completed·—·N/A·NCT05039086·13,021 enrolled
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Completed·—·N/A·NCT05768945·742,670 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)